How To Inject Tremfya Pen: Step-by-Step Patient Guide

How To Inject Tremfya Pen: Step-by-Step Patient Guide

How to Use Wegovy Injection Pens?

Administering Tremfya (guselkumab) using the single-dose One-Press autoinjector requires strict adherence to aseptic subcutaneous techniques to ensure complete drug absorption and minimize procedural discomfort. The procedure involves inspecting the prefilled solution, allowing the medication to reach ambient temperature over 30 minutes, selecting an appropriate tissue site on the abdomen or thigh, and holding 90-degree pressure until the green indicator confirms full delivery. Proper disposal in an FDA-cleared sharps container immediately following injection is mandatory to uphold biological safety standards.


Pre-Injection Preparation & Medical Checklist

Self-administration of biological therapies demands a sterile environment and systematic preparation. Tremfya is a targeted human monoclonal antibody (IL-23 inhibitor) provided in a prefilled 100 mg/mL single-dose autoinjector. Because protein-based biologics are sensitive to heat, physical agitation, and light, correct handling prior to administration directly impacts the structural integrity and bioactivity of the medication.

Before starting the injection procedure, clear a flat, well-lit workspace and assemble all clinical supplies. Never attempt to warm the device using external heat sources such as hot water, microwaves, or direct sunlight, as thermal degradation will denature the active guselkumab molecules.



  • Essential Equipment & Medical Supplies:

    • 1 Tremfya 100 mg/mL One-Press single-dose autoinjector (stored refrigerated at 36°F to 46°F / 2°C to 8°C)
    • 1 Isopropyl alcohol swab (70% concentration)
    • 1 Sterile cotton ball or 2x2-inch gauze pad
    • 1 Adhesive bandage
    • 1 FDA-cleared heavy-duty plastic sharps disposal container
  • Prerequisite Knowledge & Clinical Safety Standards:

    • Solution Inspection: The liquid in the viewing window must appear clear to light yellow. It may contain small translucent or white protein particles. Do not use if the fluid is discolored, cloudy, or contains large floating debris.
    • Site Integrity: Never inject into areas where the skin is tender, bruised, erythematous (red), indurated (hardened), thick, scaly, or actively affected by psoriasis plaques.
    • Frequency Schedule: Standard dosing for moderate-to-severe plaque psoriasis or psoriatic arthritis typically follows a Week 0, Week 4, and subsequent 8-week maintenance schedule under provider guidance.
  • Benchmark Operational Parameters:

    • Acclimation Duration: 30 minutes at controlled ambient room temperature (59°F to 77°F / 15°C to 25°C).
    • Injection Hold Time: 10 to 15 seconds of continuous downward pressure until the green confirmation indicator fully locks into view.
    • Rotation Radius: Minimum of 1 to 2 inches away from the previous injection site to prevent localized lipodystrophy or cutaneous fibrosis.

Step-by-Step Tremfya One-Press Pen Administration Protocol



Step 1: Acclimation and Visual Inspection

Remove the Tremfya carton from cold storage. Peel open the outer tray and pull the autoinjector straight out by grasping the middle of the device body. Place the pen on a clean, flat surface away from direct heat and light, leaving it undisturbed for exactly 30 minutes to adjust to room temperature. Injecting cold solution causes localized subcutaneous pain and tissue resistance. Check the expiration date printed on the back panel of the device. Look closely through the clear viewing window; the solution should be clear to pale yellow.

Warning: Do not shake the autoinjector at any point during preparation or administration. Agitation causes shear stress that can aggregate monoclonal antibodies, rendering the treatment ineffective or increasing immunogenicity risk.



Step 2: Anatomical Site Selection and Aseptic Preparation

Select an appropriate subcutaneous administration zone:



  1. Thigh Region: The upper, outer anterior portion of the thigh is ideal for self-injection.
  2. Abdominal Region: The lower abdomen, staying at a strict 2-inch (5 cm) radius clear of the umbilicus (navel).
  3. Upper Arm Region: The outer posterior aspect of the upper arm may be used only if an trained caregiver is administering the injection.

Uncover the chosen area. Saturate the skin by wiping a 70% isopropyl alcohol swab in an expanding concentric circular motion over a 2-inch diameter. Allow the site to air-dry completely for 30 seconds. Do not blow on, fan, or touch the clean skin prior to needle insertion.

Pro-Tip: Allowing the alcohol to evaporate completely prevents the rapid chemical stinging sensation caused when residual alcohol is carried through the epidermis by the needle.



Step 3: Uncapping the Autoinjector

Hold the body of the Tremfya pen firmly with one hand. Grasp the bottom protective cap with the other hand and pull it straight off. Discard the cap immediately. You will notice the yellow needle guard extending from the bottom of the device; this guard conceals the internal non-visible needle and acts as the safety trigger mechanism. Perform the injection within 5 minutes of removing the cap to avoid contamination or needle drying.

Warning: Never attempt to re-cap the Tremfya One-Press pen once removed, and do not touch or push against the yellow needle guard with your fingers. This can trigger the internal spring mechanism or cause an accidental needle-stick injury.



Step 4: Positioning and Executing the Subcutaneous Push

Sit or stand comfortably to stabilize the target tissue zone. Place the open end of the autoinjector flat against the sanitized skin at a perpendicular 90-degree angle.



  1. Press the autoinjector down firmly against the skin. As you push downward, the yellow needle guard will retract into the device handle, exposing and inserting the internal needle while initiating drug delivery.
  2. Maintain continuous, firm downward pressure against the skin. You may hear an initial audible click indicating the start of the injection process.
  3. Observe the clear viewing window on the side of the pen body. A green indicator bar will steadily move across the window as the liquid pushes into the subcutaneous tissue space.
  4. Keep pushing down until the green indicator completely fills the viewing window and stops moving. Continue holding for a full 5 seconds after the window turns entirely green to ensure the full 1.0 mL dose is absorbed.

Pro-Tip: Do not tilt, angle, or slide the autoinjector across the skin surface during depression. Keeping the device strictly vertical at 90 degrees prevents skin shearing and ensures complete mechanical stroke clearance.



Step 5: Safe Device Withdrawal and Post-Care

Lift the autoinjector straight up off the skin. As the device is raised, the yellow needle guard automatically extends downward and locks permanently over the exposed needle, preventing post-procedural needle-stick hazards.

Examine the injection site. If a minor drop of blood or interstitial fluid is present, press a sterile cotton ball or gauze pad lightly over the site for 10 to 15 seconds. Do not rub or massage the injection site, as this alters drug absorption dynamics and can induce local bruising. Apply a small adhesive bandage if necessary. Immediately drop the used autoinjector into a heavy-duty, puncture-resistant sharps container.


How to Use Tremfya for Psoriasis and Psoriatic Arthritis - GoodRx

How to Use Tremfya for Psoriasis and Psoriatic Arthritis - GoodRx

Tremfya Pen Technical Specifications & Site Matrix



Operational Parameter Clinical Specification / Standard
Active Molecule Guselkumab (Human IgG1λ monoclonal antibody)
Dose / Volume Concentration 100 mg per 1.0 mL solution in single-dose autoinjector
Storage Thermal Range 36°F to 46°F (2°C to 8°C); Protect from light; Do NOT freeze
Room Temperature Stability Max 30 minutes ambient (59°F–77°F / 15°C–25°C) prior to use
Needle Gauge & Depth Internal 27-gauge ultra-thin wall needle; ~1/2 inch penetration depth
Primary Injection Sites Anterior thigh, lower abdomen (>2 inches from navel)
Secondary Injection Site Outer rear upper arm (Caregiver administration only)
Mechanical Confirmation Green indicator filling 100% of the viewing window

Injection Failure Modes & Technical Solutions



Scenario 1: Droplets of Medication Appear on the Skin Surface



  • Root Cause: Premature withdrawal of the autoinjector before the plunger completes its downward travel, or failure to maintain adequate 90-degree downward force against resistance.
  • Actionable Fix: Maintain firm vertical pressure without slipping. Ensure the window is entirely filled with the green confirmation indicator, then count to 5 before lifting the device. Do not re-inject or give a second pen if partial leakage occurs; document the estimated fluid loss and contact your prescribing clinic for guidance.


Scenario 2: The Green Indicator Window Stops Mid-Way or Jams



  • Root Cause: Mechanical obstruction within the spring mechanism, tilting the pen mid-injection, or attempting to penetrate densely scarred/fibrotic dermal tissue.
  • Actionable Fix: Lift the pen straight up off the skin to allow the safety shield to lock over the needle. Inspect the window to gauge how much medication was delivered. Do not attempt to force, twist, or push the pen back down into the skin. Retain the blocked device and call Janssen CarePath or your specialty pharmacy for a free replacement logged under device quality control.


Scenario 3: Intense Burning or Stinging During Administration



  • Root Cause: Injecting cold drug solution straight from refrigerator storage, or failing to allow the alcohol preparation pad liquid to evaporate completely.
  • Actionable Fix: Strict adherence to the 30-minute room temperature acclimation rule is necessary to lower fluid viscosity and match body comfort thresholds. Ensure the skin surface is completely dry to the touch before uncapping the device.


Scenario 4: Accidental Dropping of Uncapped Autoinjector



  • Root Cause: Loss of tactile grip or unsteady patient positioning during the uncapping stage.
  • Actionable Fix: Do not use an autoinjector that has been dropped with its bottom cap removed. The unshielded needle tip may be bent, burred, or non-sterile. Discard the dropped device directly into your sharps container and restart the process with a fresh, sterile unit.

Frequently Asked Questions



What should I do if I forget to take my scheduled Tremfya dose?

If you miss a dose, inject the Tremfya pen as soon as you remember. After taking the missed dose, recalculate your dosing schedule so that your next dose is administered based on your standard interval (typically every 8 weeks) from that new date. Contact your prescribing physician or dermatologist to confirm your adjusted treatment calendar, and never double-dose to make up for a missed administration.



Can I self-inject Tremfya into my upper arm?

Self-injection into the upper arm is not recommended due to anatomical angles and the difficulty of maintaining consistent downward pressure. The outer back of the upper arm can be utilized only if an instructed caregiver, nurse, or healthcare provider performs the injection while you keep your arm relaxed.



Is it normal to see an air bubble inside the Tremfya viewing window?

Yes, seeing small air bubbles in the viewing window is entirely normal and expected in prefilled biologic autoinjectors. You do not need to purge or bleed the air bubble before injecting. The autoinjector is engineered to safely handle small air pockets without impacting subcutaneous dose delivery or causing harm.



How should I dispose of my used Tremfya autoinjector if I am traveling?

When traveling, carry a portable, puncture-resistant travel sharps container or a rigid, heavy-duty plastic container with a leak-proof lid (such as a empty detergent bottle). Never dispose of used biological pens in standard household trash, recycling bins, or public receptacles. Follow local municipal regulations for FDA-compliant biohazard waste disposal.

Optimize Your Biologic Therapy Protocol

Consistently following precise administration techniques ensures maximum drug bioactivity, minimal injection discomfort, and superior control over chronic inflammatory disease symptoms. For additional assistance with injection training, insurance navigation, or replacement requests for damaged devices, contact your clinical care manager or reach out directly to the official Tremfya patient support system.


How To Use Mounjaro Injection Pen

How To Use Mounjaro Injection Pen

Read also: Expanded online memorial features are coming to fair funeral home obits eden nc